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Background: This study assessed the validity of the Resident Assessment Instrument Minimum Data Set (RAI-MDS)
Version 2.0 for diagnoses of diabetes and comorbid conditions in residents of long-term care facilities (LTCFs).
Methods: Hospital inpatient, outpatient physician billing, RAI-MDS, and population registry data for 1997 to 2011
from Saskatchewan, Canada were used to ascertain cases of diabetes and 12 comorbid conditions. Prevalence
estimates were calculated for both RAI-MDS and administrative health data. Sensitivity, specificity, and positive and
negative predictive values (PPV and NPV) were calculated using population-based administrative health data as the
validation data source. Cohen’s κ was used to estimate agreement between the two data sources.
Results: 23,217 LTCF residents were in the diabetes case ascertainment cohort. Diabetes prevalence was 25.3% in
administrative health data and 21.9% in RAI-MDS data. Overall sensitivity of a RAI-MDS diabetes diagnoses was 0.79
(95% CI: 0.79, 0.80) and the PPV was 0.92 (95% CI: 0.91, 0.92), when compared to administrative health data.
Sensitivity of the RAI-MDS for ascertaining comorbid conditions ranged from 0.21 for osteoporosis to 0.92 for
multiple sclerosis; specificity was high for most conditions.
Conclusions: RAI-MDS clinical assessment data are sensitive to ascertain diabetes cases in LTCF populations when
compared to administrative health data. For many comorbid conditions, RAI-MDS data have low validity when
compared to administrative data. Risk-adjustment measures based on these comorbidities might not produce
consistent results for RAI-MDS and administrative health data, which could affect the conclusions of studies about
health outcomes and quality of care across facilities.
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Diabetes affects a high proportion of older adults and
confers an increased risk for such conditions as hyper-
tension, myocardial infarction, and stroke. Long-term
care facilities (LTCFs), which provide housing, support,
and nursing care for individuals who are no longer able
to function independently, include a large and increasing
number of residents with diabetes. The estimated preva-
lence of diabetes is much higher in LTCF populations
than in the general population [1]. A 2002 US study* Correspondence: lisa.lix@med.umanitoba.ca
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reproduction in any medium, provided the orreported a diabetes prevalence of 26.4% in LTCF resi-
dents, which was more than 30% higher than the esti-
mate for the population 60+ years [2]. A more recent
study estimated the prevalence to be even higher, at
32.8% [3].
Given the heavy demands that residents with diabetes
can place on LTCF resources, information about dia-
betes is important for monitoring health outcomes and
quality of care in LTCFs. As well, risk-adjustment
methods, which are constructed using data about co-
morbid conditions, are essential to ensure fair compari-
sons across facilities or resident sub-populations when
measuring outcomes.
Electronic, population-based data sources for ascer-
taining chronic and acute conditions in LTCFs includeThis is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cords, and clinical assessment data, like the Resident As-
sessment Instrument Minimum Data Set (RAI-MDS)
[4-6]. To date, comparisons of disease diagnostic infor-
mation captured in these two data sources have been
limited. Mor et al. [6] found that diagnoses in RAI-MDS
data had fair to good sensitivity and specificity but low
positive predictive value (PPV) when compared to diag-
noses in hospital records for residents admitted to
LTCFs from acute care hospitals. Wodchis et al. [7] ob-
tained similar results. However, neither of these studies
assessed validity of the diagnoses captured in the RAI-
MDS for the entire LTCF resident population, not just
those admitted from hospital, nor did they use both in-
patient and outpatient data as the validation data source
when assessing the validity of the RAI-MDS data.
The primary purpose of this study was to investigate the
validity of diabetes diagnosis information recorded in
population-based RAI-MDS. The secondary purpose was
to investigate the validity of RAI-MDS diagnoses for co-
morbid conditions amongst LTCF residents with a diabetes
diagnosis. Administrative health data were the validation
source for both analyses.
Methods
Data sources
Population-based data from the province of Saskatch-
ewan, Canada, which has a population of approximately
1.1 million according to the 2011 Statistics Canada Cen-
sus, was used to conduct this study. Like all Canadian
provinces, Saskatchewan has a universal health care
program. The provincial ministry of health maintains
health care databases in electronic format and these
can be anonymously linked via a unique personal health
number [8].
RAI-MDS Version 2.0, hospital inpatient records, out-
patient physician billing claims, population registry records,
and records from the provincial Institutional Supportive
Care Home (ISCH) database were used to conduct the
study. The RAI-MDS, originally developed by researchers
under contract with the US Centers for Medicare and Me-
dicaid Services, contains information about care and func-
tioning of LTCF residents. This includes diagnoses for
conditions that may affect activities of daily living, cognitive
status, mood and behavior status, medical treatments,
monitoring, and/or mortality risk. The data are collected
via observations and documentation by LTCF staff and/or
by interview with residents, relatives or doctors providing
care to residents. Forms are required to be completed
within 14 days of admission to a LTCF, as well as quarterly
and annually thereafter, as well as whenever there is a major
change in a resident’s health status. Saskatchewan was the
first Canadian province to make the RAI-MDS mandatory
in all LTCFs, in April 2001, although full implementationdid not occur until 2004. RAI-MDS data from fiscal year
2005/06 (a fiscal year extends from April 1 to March 31) to
2011/12 (the most recent year of available data) were used
in this study.
A hospital record is completed when a patient is dis-
charged from an acute care facility. Diagnoses in hospital
data are captured using ICD-9 up to and including the
2000/01 fiscal year. Beginning in 2001/02, diagnoses are
recorded using ICD-10-CA. Between three and 16 diag-
noses are captured in the data prior to the introduction
of ICD-10-CA and up to 25 diagnoses are captured sub-
sequently. Physicians paid on a fee-for-service basis sub-
mit billing claims to the ministry of health for payment
purposes. A single diagnosis is recorded on each claim
using ICD-9 codes. Some physicians, particularly special-
ists, are salaried and may not consistently submit billing
claims. Hospital records and physician billing claims for
fiscal years 1997/98 to 2011/12 were available.
The population registry contains dates of health insur-
ance coverage, demographic information such as date of
birth and sex, and location of residence. Registry data
for fiscal years 1997/98 to 2011/12 were available.
The ISCH database contains information on new admis-
sions, discharges, or changes in level of care classification
for residents of LTCFs. The database also contains infor-
mation on the characteristics of facilities.
The quality of Saskatchewan’s administrative health data
for research has been documented in multiple studies
[9-12]. Ethics approval for database access was received
from the University of Saskatchewan Biomedical Research
Ethics Board. Data were accessed and analyzed at the
Health Quality Council in accordance with a standing data
sharing agreement between the organization and the pro-
vincial health ministry.
Study design
This study adopted a retrospective cohort design. The
inclusion criteria for the diabetes case ascertainment co-
hort were: (a) an RAI-MDS admission or annual assess-
ment between April 1, 2005 and March 31, 2011, and
(b) continuous health insurance coverage between April
1, 1997 and the study index date. RAI-MDS quarterly
assessments were not used to define the cohort because
they lack complete information on diagnoses. The index
date was the date that a diabetes diagnosis first appeared
in an RAI-MDS admission or annual assessment be-
tween April 1, 2005 and March 31, 2011. If a person did
not have a diabetes diagnosis in the RAI-MDS data dur-
ing this time period, then the date of the first RAI-MDS
admission or annual assessment between April 1, 2005
and March 31, 2011 was the index date.
The comorbidity case ascertainment cohort was a subset
of the diabetes case ascertainment cohort. The inclusion
criteria were: (a) diagnosis of diabetes in either RAI-MDS
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continuous health insurance coverage after the study index
date, which is the same date as defined for the diabetes case
ascertainment cohort. This coverage period was selected to
allow for the potential diagnosis of comorbid conditions
following a diabetes diagnosis.
Study variables
Diagnosis information for diabetes and comorbid condi-
tions was extracted from the RAI-MDS, hospital re-
cords, and physician billing claims. Socio-demographic
variables were defined using the registry data. Informa-
tion about LTCF characteristics was obtained from the
ISCH data.
Diabetes cases were identified from the RAI-MDS data
by searching for the first occurrence of a diabetes diag-
nosis in admission and annual assessments between
April 1, 2005 and March 31, 2011. Diabetes cases from
administrative health data were individuals who met a
validated case definition for diabetes in hospital records
or physician billing claims between April 1, 1997 and
the study index date, inclusive (Table 1).
We selected 12 comorbid conditions for which a vali-
dated case definition had been developed using diagno-
ses in hospital records and/or physician billing claims
(Table 1), and for which diagnostic information was also
available in the RAI-MDS Version 2.0: Alzheimer’s dis-
ease or dementia, arthritis, cardiac dysrhythmia, congest-
ive heart failure, chronic obstructive pulmonary disease,
glaucoma, hip fracture, hypertension, multiple sclerosis,
osteoporosis, Parkinson’s disease, and stroke or transient
ischemic attack. In the administrative data, stroke was
the only condition defined exclusively from hospital re-
cords, while all other conditions were defined from both
hospital records and physician billing claims. For all co-
morbid conditions, the observation window for case as-
certainment extended from 365 days before to 365 days
after the study index date in both the RAI-MDS and ad-
ministrative health data.
Socio-demographic variables included age, sex, region
of residence, and income quintile. All variables were de-
fined at the study index date, except for income quintile,
which was defined from the residence location one year
prior to the index date. Age was classified as less than
65 years, 65 to 74 years, 75 to 84 years, and 85+ years.
Rural and urban region of residence was based on postal
code; a resident was categorized as living in an urban
area if his/her postal code was in a Census Metropolitan
Area or Census Agglomeration Area with a population
of 10,000 or more. Income quintile was defined using a
method based on average household income for Statis-
tics Canada Census dissemination areas (DAs) [26]. DAs
are the smallest geographic unit for which Census data
are reported; each individual was assigned a DA basedon his/her postal code; the highest quintile was the
reference.
The Charlson comorbidity index score was computed
for each resident. It was based on ICD diagnoses cap-
tured in hospital records and physician billing claims for
the one-year period prior to the study index date and
categorized as 0, 1 to 2, and 3 or more.
Facility type and affiliation were defined at the study
index date. LTCFs were classified as special care home
or other facility. The former are public facilities for
which residence is determined based on need, while the
latter are typically private facilities. LTCF affiliation in-
cludes amalgamate, affiliate, and contract. Health regions
in the province may operate facilities on their own, or
the facility may be operated by an independent health
care organisation, or through a contract for services with
an independent organization.
Statistical analysis
Frequencies, percentages, means, and standard devia-
tions (SDs) were used to describe the study cohort on
socio-demographic and Charlson comorbidity variables.
Crude prevalence estimates (percentages) were calcu-
lated for disease diagnoses in both data sources.
Sensitivity and specificity were estimated for diagnoses
recorded in RAI-MDS data. Sensitivity was defined as
the proportion of true positives that RAI-MDS detected
among all positive disease cases. Positive disease cases
were LTCF residents identified as having the disease in
administrative health data based on the validated case
definition for the disease. Specificity was defined as the
proportion of true negatives the RAI-MDS detected
among all negative disease cases. Negative disease cases
were LTCF residents identified as not having the disease
in administrative health data based on the validated case
definition for the disease.
Positive predictive value (PPV) and negative predictive
value (NPV) were also estimated for the RAI-MDS diag-
noses. PPV refers to the proportion of LTCF residents
with a RAI-MDS diagnosis for a specific disease among
all LTCF residents who had the disease diagnosis. NPV
refers to the proportion of LTCF residents without a
RAI-MDS diagnosis amongst those residents who did
not have the disease diagnosis.
Cohen’s κ was used to estimate agreement between the
RAI-MDS and administrative health data. The interpret-
ation of κ adopted in this study was [27]: κ < 0.20 is poor
agreement, 0.20 ≤ κ ≤ 0.39 is fair agreement, 0.40 ≤ κ ≤
0.59 is moderate agreement, 0.60 ≤ κ ≤ 0.79 is good
agreement, and κ ≥ 0.80 is very good agreement.
For diabetes, overall estimates were produced for each
of the indices of sensitivity, specificity, PPV, NPV, and κ.
In addition, separate estimates were produced by age
group (i.e., less than 65 years, 65 years and older), sex,
Table 1 Case definitions applied to administrative health data for diabetes and comorbid conditions
Condition Case definition algorithm
Diabetes [13,14] One or more inpatient hospital separations with an ICD code in any diagnosis field or two or more physician
billing claims within two years with an ICD code.
ICD-9: 250
ICD-10-CA: E10, E11, E12, E13, E14
Alzheimer’s disease/dementia [15] One or more inpatient hospital separations with an ICD code in any diagnosis field or one or more physician
billing claims with an ICD code.
ICD-9: 290, 291, 294, 331
ICD-10-CA: F00, F01, F02, F03, F05.1, G30, G31.1
Arthritis [16,17] One or more inpatient hospital separations with an ICD code in any diagnosis field or one or more physician
billing claims with an ICD code.
ICD-9: 714, 715, 446, 710, 720, 274, 711, 712, 713, 716,
717, 718 719, 721, 725 to 729, 739
ICD-10-CA: M05, M06, M15 to M19, M07, M10, M11 to M14, M30 to M36, M00 to M03, M20 to M25, M65 to M79
Cardiac dysrhythmia [17] One or more inpatient hospital separations with an ICD code in any diagnosis field or one or more physician
billing claims with an ICD code.
ICD-9: 427
ICD-10-CA: I47, I48, I49
Congestive heart failure [18,19] One or more inpatient hospital separations with an ICD code in any diagnosis field or one or more physician





One or more inpatient hospital separations with an ICD code in any diagnostic field or one or more physician
billing claims with an ICD code.
ICD-9 code: 491, 492, 496
ICD-10-CA: J41, J42, J43, J44
Glaucoma [18] One or more inpatient hospital separations with an ICD code in any diagnosis field or one or more physician
claims with an ICD code.
ICD-9 code: 365
ICD-10-CA: H40, H42
Hip fracture [20] One or more inpatient hospital separations with an ICD code in the first diagnosis field.
ICD-9: 820
ICD-10-CA: S72.0, S72.1, S72.2
Hypertension [21,22] One or more inpatient hospital separations with an ICD code in any diagnosis field or two or more physician
claims with an ICD code within two years.
ICD-9: 401 to 405
ICD-10-CA: I10 to I13, I15
Multiple sclerosis [15] One or more inpatient hospital separations with an ICD code in any diagnosis field or one or more physician
billing claims with an ICD code.
ICD-9: 340
ICD-10-CA: G35
Osteoporosis [23,24] One or more inpatient hospital separations with an ICD code in any diagnosis field or one or more physician
billing claims with an ICD code.
ICD-9: 733.0 (hospital data) or 733 (physician data)
ICD-10-CA: M80, M81
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Table 1 Case definitions applied to administrative health data for diabetes and comorbid conditions (Continued)
Parkinson’s disease [15] One or more inpatient hospital separations with an ICD code in any diagnosis field or one or more physician
billing claims with an ICD code.
ICD-9: 332
ICD-10-CA: G20
Stroke/transient ischemic attack [25] One or more inpatient hospital separations with an ICD code in the first diagnosis field.
ICD-9: 430, 431, 432, 433, 434, 435, 436, 437, or 438
ICD-10-CA: I60, I61, I62, I63 (excluding I63.6), I64, I65, I66, I67 (excluding I67.6), I68, I69, G45, G46, H34.
Note: ICD-9 codes are used to ascertain cases in physician billing claims and in hospital records up to and including 2000/01 fiscal year; ICD-10-CA codes are used
to ascertain cases in hospital records for 2001/02 onward and ICD-9 codes are used to ascertain cases in physician billing claims for 2001/02 onward.
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versus annual). For the comorbid conditions, only over-
all estimates were produced because there were too few
cases of some conditions to conduct stratified analyses.
As well, 95% confidence intervals (CIs) were produced
for all estimates; they were based on the asymptotic
standard error and a critical value from the standard
normal distribution. Analyses were conducted using SAS
software, version 9.3. [28].
Results
The study cohort for diabetes case ascertainment con-
sisted of 23,217 LTCF residents with an average age of
83.4 years (SD = 11.4; median = 86 years). Close to two-
thirds (63.7%) were female (Table 2), and there was a
higher proportion of residents in the lowest (23.3%) than
highest income quintile (13.5%). The cohort was almost
equally split between rural and urban residents. For al-
most three-quarters (74.0%) of the cohort, the study
index date corresponded to an RAI-MDS admission
assessment.
The prevalence of diabetes (Figure 1) was 27.1% for
both data sources combined, with estimates of 25.3% for
administrative health data and 21.9% for RAI-MDS data
only. Prevalence was higher in males (32.1%) than fe-
males (24.8%) and was lower in those less than 65 years
(25.9%) than in those 65+ years (38.1%). While the
prevalence estimates from administrative health data
were slightly higher than those from the RAI-MDS data
by age and sex, there was very good agreement between
the two data sources.
For the full cohort, sensitivity of a RAI-MDS diabetes
(Table 3) was 0.79 (95% CI: 0.79, 0.80) and specificity
was 0.97 (95% CI: 0.97, 0.98). PPV and NPV estimates
were above 0.90. The estimate of Cohen’s κ was 0.81
(95% CI: 0.80, 0.82). Sensitivity, specificity, NPV, and κ
were slightly higher in younger than older age groups,
while the reverse was true for PPV. Sensitivity and speci-
ficity were similar when the index RAI-MDS assessment
was an admission rather than an annual assessment.
However, PPV was higher for the former than the latter,
as was κ.The comorbidity case ascertainment cohort, which
was a subset of the diabetes case ascertainment cohort
(N = 4,183), is described in Table 2. This cohort was
slightly younger than the diabetes case ascertainment co-
hort, with a mean age of 81.5 years (SD = 10.5; median =
84), but had higher overall comorbidity.
As Table 4 reveals, the comorbid condition with the
highest prevalence in both RAI-MDS and administrative
health data was hypertension (55.8% and 57.3%, respect-
ively), with more than half of the diabetes cohort having
a diagnosis. Prevalence was almost equally high for arth-
ritis in administrative health data (53.0%), but was sub-
stantially lower in RAI-MDS data (42.5%). Prevalence
was higher in RAI-MDS than administrative data for
one-third of the comorbid conditions, including Alzhei-
mer’s disease or dementia, glaucoma, hip fracture, and
stroke or TIA (Table 4), but higher in administrative
health data than RAI-MDS data for the remainder of the
conditions.
Validity of the RAI-MDS diagnoses for the comorbid
conditions varied substantially. Sensitivity was lowest for
osteoporosis (0.21; 95% CI: 0.20, 0.22) and highest for mul-
tiple sclerosis (0.92; 95% CI: 0.91, 0.92). Specificity was
below 0.90 for hypertension, arthritis, Alzheimer’s disease/
dementia, and stroke/transient ischemic attack. PPV esti-
mates ranged from 0.49 (95% CI: 0.47, 0.50) for osteopor-
osis to 0.72 (95% CI: 0.70, 0.73) for Parkinson’s disease.
NPV estimates ranged from 0.55 (95% CI: 0.53, 0.56) for
arthritis to 1.00 (95% CI: 1.00, 1.00) for multiple sclerosis.
Estimates of κ did not exceed 0.60 for any the comorbid
conditions except for multiple sclerosis (κ = 0.76) and
Parkinson’s disease (κ = 0.64); agreement was very low for
osteoporosis (κ = 0.13) and arthritis (κ = 0.17).
Discussion
This study validated diabetes diagnoses captured in RAI-
MDS data for LTCF residents and then further examined
the validity of multiple comorbid conditions in residents
with a diabetes diagnosis using administrative health
data as the validation data source. The findings revealed
good sensitivity and excellent specificity of the RAI-
MDS for diabetes. PPV, NPV, and κ estimates were also
Table 2 Characteristics of long-term care facility residents
in the diabetes case ascertainment cohort (N = 23,217)








< 65 years 1518 (6.5) 300 (7.2)
65 – 74 years 2090 (9.0) 554 (13.2)
75 – 84 years 7187 (31.0) 1517 (36.3)
85+ years 12422 (53.5) 1812 (43.3)
Sex
Female 14795 (63.7) 2547 (60.9)
Male 8422 (36.3) 1636 (39.1)
Charlson comorbidity index
0 7947 (34.2) 1108 (26.5)
1-2 9467 (40.8) 1552 (37.1)
3+ 5803 (25.0) 1523 (36.4)
Income quintile
Q1 (Lowest) 5400 (23.3) 1097 (26.2)
Q2 4814 (20.7) 887 (21.2)
Q3 5639 (24.3) 983 (23.5)
Q4 4072 (17.5) 693 (16.6)
Q5 (Highest) 3143 (13.5) 500 (12.0)
Missing 149 (0.6) 23 (0.5)
Residence location
Rural 11796 (50.8) 2197 (52.5)
Urban 11209 (48.3) 1932 (46.2)
Missing 212 (0.9) 54 (1.3)
Facility affiliation
Affiliated 6834 (29.4) 1160 (27.7)
Amalgamated 14412 (62.1) 2686 (64.2)
Contract 1968 (8.5) 334 (8.1)
Facility type
Special care home 20002 (90.5) 3787 (90.5)
Other facility 2215 (9.5) 396 (9.5)
Diabetes prevalence (%) 6298 (27.1) 4183 (100.0)
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was substantial variability in estimates of validity and
agreement.
RAI-MDS data, while originally intended for clinical as-
sessment, are now being used to measure quality of care
and resident health outcomes across LTCFs, such as medi-
cation management and glycemic control in diabetics, [1]
as well as outcomes of care such as falls, amputations, and
skin ulcers [29]. To ensure these measures can be fairly
compared across LTCFs, it is important to use risk-
adjustment measures based on comorbid conditions, whichaccount for underlying differences in resident populations.
For example, Berlowitz et al. [30] developed a model for
predicting pressure ulcers, in which resident comorbid con-
ditions of diabetes and hip fracture were used for risk
adjustment.
While previous studies have estimated diabetes preva-
lence in LTCF populations, [1,2] there has been limited
data about the prevalence of other health conditions.
Travis et al. [2] reported a hypertension prevalence of
69.1% in LTCF residents at admission, which is substan-
tially higher than our estimates of 55.8% from RAI-MDS
data and 57.2% from administrative health data. How-
ever, for cardiac dysrhythmia, our RAI-MDS estimate
was similar (11.1%) to the estimate from this earlier
study (12.4%).
Our study reveals both similarities and differences with
previous research about the validity of diagnoses in RAI-
MDS admission assessments for residents admitted from
hospital when diagnoses captured in hospital records were
used as the validation data source. Mor et al. [6] reported a
sensitivity of 0.93 for diabetes, which is only slightly higher
than our estimate. However, PPV was only 0.69 in that
study, while our estimate exceeded 0.90. Wodchis et al. [7]
reported sensitivity of RAI-MDS diagnoses ranging from
0.16 for hypotension to 0.91 for cancer. For Alzheimer’s
disease, a common condition in LTCF residents, sensitivity
was 0.64, while for other dementia it was 0.60. Both values
are similar to the estimate of 0.71 that we observed for Alz-
heimer’s disease or dementia. Sensitivity of the RAI-MDS
data for hypertension was also similar between the two
studies. However, for osteoporosis, Wodchis et al. [7] re-
ported a sensitivity estimate of 0.65, which is substantially
higher than our estimate of 0.21.
While previous research has focused on the validity of
disease information captured in the RAI-MDS admission
assessment, the current study undertook validity com-
parisons of both admission and annual assessments for
diabetes. Sensitivity estimates were similar between the
two assessment sources, but PPV and κ estimates were
higher in the admission assessment. This difference may
reflect a lack of consistency checks amongst LTCF staff,
to ensure that conditions present on admission continue
to be recorded in follow-up assessments [31].
In Canada, the Canadian Institute for Health Informa-
tion (CIHI), a national not-for-profit agency that develops
and maintains comprehensive and integrated health in-
formation, compiles RAI-MDS data from LTCFs in its
Continuing Care Reporting System (CCRS) for seven of
the thirteen provinces and territories; the CCRS was
established in 2003 [31]. More than 1000 facilities sub-
mitted data to the CCRS in the 2011/12 fiscal year,
including all facilities in the province of Ontario and
selected facilities in other provinces and territories. The
CCRS maintains standards for data element specifications,
Figure 1 Prevalence of diagnosed diabetes in RAI-MDS data and administrative health data by sex and age group.
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rules. Quality of the data submitted to the CCRS is evalu-
ated annually. Saskatchewan currently submits its RAI-
MDS data to CIHI, although not via the CCRS and the
Saskatchewan data are therefore not included in national
quality reports [32]. This may affect the generalizability of
the current study findings to other Canadian provinces
and territories.
There are several potential reasons for the differences
between the RAI-MDS data and administrative health
data for ascertaining cases of diabetes and comorbid con-
ditions; both data sources have strengths and limitations.Table 3 Estimates of validation and agreement measures for
ascertainment cohort (N = 23,217)
Sens. (95% CI) Spec. (95%
Full cohort 0.79 (0.79, 0.80) 0.98 (0.97, 0.9
Females 0.79 (0.78, 0.79) 0.98 (0.98, 0.9
Males 0.81 (0.80, 0.82) 0.97 (0.97, 0.9
< 65 years 0.86 (0.84, 0.88) 0.96 (0.96, 0.9
65+ years 0.79 (0.79, 0.80) 0.98 (0.97, 0.9
Admission RAI-MDS assessment 0.79 (0.79, 0.80) 0.98 (0.98, 0.9
Annual RAI-MDS assessment 0.80 (0.79, 0.81) 0.96 (0.96, 0.9
Sens. = sensitivity; Spec. = specificity; PPV = positive predictive value; NPV = negativConditions recorded in the RAI-MDS are limited to “ac-
tive” conditions that affect resident activities of daily living,
cognition, mood, or behavior. Conditions that are present,
but that have minimal impact on resident day-to-day func-
tion, such as osteoporosis, are less likely to be recorded in
the RAI-MDS data. A longer time frame than was used in
the current study may be needed to capture information
about comorbid conditions in the RAI-MDS. Some condi-
tions such as osteoporosis may have a higher probability
of capture in primary care data (i.e., physician claims) be-
cause ongoing treatment with prescription medications
may result in multiple visits to physicians. Second, LTCFdiagnosed diabetes in RAI-MDS data for the diabetes case
CI) PPV (95% CI) NPV (95% CI) κ (95% CI)
8) 0.92 (0.91, 0.92) 0.93 (0.93, 0.94) 0.81 (0.80, 0.82)
8) 0.91 (0.91, 0.93) 0.94 (0.94, 0.94) 0.80 (0.79, 0.82)
7) 0.92 (0.92, 0.93) 0.92 (0.92, 0.93) 0.81 (0.79, 0.82)
7) 0.87 (0.86, 0.89) 0.96 (0.95, 0.97) 0.83 (0.79, 0.86)
8) 0.92 (0.92, 0.92) 0.93 (0.93, 0.93) 0.80 (0.80, 0.81)
8) 0.94 (0.93, 0.94) 0.93 (0.92, 0.93) 0.81 (0.80, 0.82)
7) 0.85 (0.84, 0.86) 0.95 (0.94, 0.95) 0.78 (0.76, 0.80)
e predictive value; CI = confidence interval.
Table 4 Estimates of prevalence, validation and agreement measures for comorbid conditions in RAI-MDS data for the comorbidity case ascertainment
cohort (N = 4,183)
Condition RAI-MDS Prev. (%) Admin. data prev. (%) Sens. (95% CI) Spec. (95% CI) PPV (95% CI) NPV (95% CI) κ (95% CI)
Hypertension 55.8 57.3 0.68 (0.67, 0.70) 0.61 (0.59, 0.62) 0.70 (0.69, 0.72) 0.59 (0.57, 0.60) 0.29 (0.26, 0.32)
Congestive heart failure 18.7 31.8 0.39 (0.37, 0.40) 0.91 (0.90, 0.92) 0.66 (0.65, 0.68) 0.76 (0.75, 0.77) 0.33 (0.30, 0.37)
Arthritis 42.5 53.0 0.51 (0.49, 0.52) 0.67 0.65, 0.68) 0.63 (0.62, 0.65) 0.55 (0.53, 0.56) 0.17 (0.14, 0.20)
COPD 9.6 13.8 0.44 (0.42, 0.45) 0.96 (0.95, 0.96) 0.63 (0.61, 0.64) 0.91 (0.91, 0.92) 0.45 (0.41, 0.49)
Multiple sclerosis 2.0 1.4 0.92 (0.91, 0.92) 0.99 (0.99, 1.00) 0.65 (0.64, 0.67) 1.00 (1.00, 1.00) 0.76 (0.68, 0.84)
Parkinson`s disease 5.0 5.9 0.61 (0.60, 0.63) 0.99 (0.98, 0.99) 0.72 (0.70, 0.73) 0.98 (0.97, 0.98) 0.64 (0.59, 0.69)
Cardiac dysrhythmia 11.1 26.7 0.27 (0.26, 0.28) 0.95 (0.94, 0.95) 0.65 (0.64, 0.67) 0.78 (0.77, 0.79) 0.27 (0.24, 0.30)
AD/dementia 44.2 31.9 0.71 (0.70, 0.73) 0.69 (0.67, 0.70) 0.52 (0.50, 0.53) 0.84 (0.83, 0.85) 0.36 (0.34, 0.39)
Glaucoma 7.6 7.2 0.53 (0.51, 0.54) 0.96 (0.95, 0.97) 0.50 (0.49, 0.52) 0.96 (0.96, 0.97) 0.48 (0.43, 0.53)
Osteoporosis 13.5 31.4 0.21 (0.20, 0.22) 0.90 (0.89, 0.91) 0.49 (0.47, 0.50) 0.71 (0.70, 0.73) 0.13 (0.10, 0.16)
Hip fracture 10.2 8.9 0.62 (0.60, 0.63) 0.95 (0.94, 0.96) 0.54 (0.52, 0.55) 0.96 (0.96, 0.97) 0.53 (0.49, 0.58)
Stroke/TIA 30.6 45.5 0.65 (0.63, 0.66) 0.81 (0.80, 0.82) 0.53 (0.52, 0.55) 0.87 (0.86, 0.88) 0.42 (0.39, 0.45)
Note: COPD = chronic obstructive pulmonary disease; AD = Alzheimer’s Disease; TIA = transient ischemic attack; Sens. = sensitivity; Spec. = specificity; PPV = positive predictive value; NPV = negative predictive value;




















Lix et al. BMC Health Services Research 2014, 14:17 Page 9 of 10
http://www.biomedcentral.com/1472-6963/14/17staff may not comprehensively record data in the assess-
ment tool because of competing demands on their time;
they may therefore focus on recording information about
patient functional abilities rather than health conditions
[7]. This too may account for the lower prevalence of sev-
eral comorbid conditions in the RAI-MDS data. Staffing
levels within facilities may affect the time available for
LTCF staff to record assessment data. Residents may be
admitted near the end of life, limiting the number of as-
sessment opportunities to capture diagnostic information.
Given that LTCF residents, particularly those with dia-
betes, are likely to have many outpatient and inpatient
healthcare contacts to manage and treat their multiple
health conditions, there may be more opportunities to
capture disease diagnoses in administrative health data, al-
though this may also result in an increased rate of false
positive cases. For some high-prevalence conditions in
LTCF residents such as Alzheimer’s disease/dementia,
RAI-MDS data, despite having low sensitivity when com-
pared to administrative health data, may have advantages
over administrative health data for case ascertainment be-
cause LTCF staff may be more sensitive to the signs and
symptoms of the disease than physicians.
This study has some limitations. We selected only a
single case definition to apply to administrative health
data for ascertaining cases of diabetes and comorbid
conditions; different results may have been obtained
with case definitions having different magnitudes of sen-
sitivity and specificity. As well, estimates of validity will
be affected by the choice of validation data sources; dif-
ferent estimates may have been obtained using the med-
ical chart(s) of patients as the validation data source. We
did not include all chronic conditions for which data are
available in the RAI-MDS, instead limiting attention to
conditions for which a validated algorithm existed for
administrative health data. Finally, while our study re-
sults highlight some issues with the validity of disease
diagnosis information in the RAI-MDS, they do not sug-
gest how validity may be improved.
Conclusions
In summary, this study found that validity of diagnostic
information in RAI-MDS was very good for diabetes but
variable, and generally poorer, for comorbid chronic
conditions when administrative health data were used as
the validation data source. Based on the study results, we
recommend that researchers can use either RAI-MDS or
administrative health data to define population-based co-
horts of LTCF residents with diabetes for observational
studies; either data source will produce comparable re-
sults. However, for risk adjustment, we recommend using
linked hospital records and physician billing claims be-
cause these data are more likely to capture a broad range
of comorbid conditions. Erring on the side of caution byincluding as many comorbid conditions as may likely be
present in LTCF residents is wise, given that unmeasured
confounding can attenuate the association between disease
status and health outcomes [33].
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